Antibodies neutralizing the infectivity of influenza virus are directed against the haemagglutinin (HA) (Laver & Kilbourne, 1966) . Changes in the structure of the HA affecting its interaction with virus-neutralizing monoclonal antibodies abolish both the ability of the antibody to inhibit haemagglutination (HI) and to neutralize infectivity, although binding to the virion surface, estimated by radioimmunoassay, may in certain cases be unaffected (Kendal et al., 1981) . Sometimes, as reported by Yoden et al. (1982) for polyclonal sera, and by Kida et al. (1982) for monoclonal antibodies, the antibody may exert a virus-neutralizing effect in the absence of anti-haemagglutinating activity. In these cases, the neutralization of infectivity is due, most likely, to the impairment of a post-attachment event, e.g. the fusion of viral and cellular membranes (Kida et al., 1983) . In the present paper, we describe an inverse situation, that is, the changes in H 1N 1 influenza virus HA leading to the acquisition of resistance to two monoclonal antibodies in the virus neutralization (VN) test together with the conservation of susceptibility to these antibodies in the HI test.
The influenza H 1N 1 virus strain A/USSR/90/77 was obtained from the collection of the D. I. Ivanovsky Institute of Virology. Selection of monoclonal antibody-resistant variants was performed by treatment of 107 to 108 EIDso of A/USSR/90/77 virus with an excess of antibody [256 to 1024 anti-haemagglutinating units (anti-HAU) as determined by titration against 8 HAU]. Serial tenfold dilutions of the virus-antibody mixture were inoculated into the allantoic cavity of 10-day-old chick embryos (15 to 20 embryos/dilution). Subsequent cloning was performed by three successive limiting dilution passages without antibodies. The preparation of the mouse-adapted variants has been described in a previous publication (Gitelman et al., 1984) . Briefly, the virus was passaged in mice by intranasal infection; mice were sacrificed 48 h after inoculation, and a suspension of their lungs was used for the next passage. The 3rd and the 12th 0000-7101 © 1986 SGM Short communication passage variants (IIIp and XIIp, respectively) were used in these studies; the variants were cloned by three successive limiting dilution passages in chick embryos.
HI and VN tests were performed in conventional ways. Clarified (either undiluted or diluted 1:10) allantoic fluid (containing 32 to 256 HAU and 107 to 108 EIDs0 of the virus) was incubated with an excess of antibody (512 to 1024 HIU as determined by titration against 8 HAU in the HI test). The mixture was incubated for 1 h at 20 °C, and tenfold serial dilutions were prepared and inoculated into the allantoic cavity of chick embryos (six to eight embryos/dilution). A sample incubated with normal mouse serum or ascites fluid diluted 1 : 10 was used as a control. The endpoint of titration was determined by the method of Kaerber. Two procedures of the HI test were used. One, performed in parallel with the VN test, included the titration of the same virus-antibody mixture as used in the VN test. Twofold dilutions were prepared and an equal volume of 1% suspension of chicken red blood cells added. The other procedure included the titration of the antibodies (starting from 1 : 100 dilution) against 8 HAU of the virus.
Monoclonal antibodies were prepared against A/Brasil/ll/78 (H1N1). The titres of the antibody preparations in HI tests against the original A/USSR/90/77 virus ranged from 1 : 6400 to 1:102400. Anti-immunoglobulin serum was obtained by immunization of guinea-pigs with the IgG fraction of mouse serum obtained by Protein A-Sepharose chromatography (Ey et al., 1978) . The animals were inoculated three times at 14-day intervals, with complete Freund's adjuvant, and once without adjuvant, the overall dose of protein being 300 gg/animal. The titre of anti-IgG serum in the double-diffusion test against 10 gg-mouse IgG was 1:64.
For labelling of virus-specific proteins MDCK cells were infected with 40 to 80 EIDs0/cell of the virus and labelled with 14C-amino acids (20 gCi/ml in Eagle's MEM) from 2 to 5 h postinfection. The cells were washed with saline, lysed in the dissociation buffer for PAGE (Laemmli, 1970) and analysed by electrophoresis in slab gels. The gels were dried and exposed to X-ray film for autoradiography.
We first looked at the reactions of mouse-adapted variants of the A/USSR/90/77 strain with a set of monoclonal antibodies against a closely related strain A/Brasil/11/78. In our previous studies, we had registered a loss of the ability of A/USSR/90/77 to react in the HI test with two monoclonal antibodies (HC 22 and HC 124) after serial passage of the virus in mice. The loss occurred at the 2nd or 3rd passage, before the acquisition of pathogenicity for mice, which occurred at the 9th or 10th passage (Gitelman et al., 1984) .
Further studies of the mouse-adapted variants revealed that two other antibodies, HC 125 and HC 142, which efficiently inhibited the mouse-adapted virus in the HI test (Table 1) , failed to neutralize their infectivity (Table 2 ). This dissociation of the ability to react in the HI and VN tests with HC 125 and HC 142 was probably acquired concomitantly with resistance to HC 22 and HC 124, since the variants IIIp and XIIp behaved similarly.
This pattern of reactivity was not specific for the mouse-passaged virus. A variant selected with an excess of HC 22 antibody from the original A/USSR/90/77 strain (Res 22) behaved in the same way: it was completely resistant to HC 22 and HC 124, yet it was resistant to HC 125 and HC 142 only in VN tests. Moreover, variants selected with HC 142 (Res 142-1 and Res 142-2) behaved in a similar manner (Table 2) . However, the infectivity of all the variants, mousepassaged and antibody-selected, was neutralized with HC 125 and HC 142 monoclonal antibodies in the presence of anti-immunoglobulin serum (Table 3) .
PAGE of labelled virus-specific proteins revealed differences in the mobilities of the HA bands among the variants of strain A/USSR/90/77 (Fig. 1) . The HA of the original virus formed two bands, which is fairly characteristic of influenza virus replicating in MDCK cells (Sklyanskaya et al., 1980) , the lower band being, most likely, an underglycosylated form of HA. The mouse-adapted variant XIIp exhibited a single band, moving faster than the main component of the HA of the original virus. Variant IIIp produced one band with an intermediate mobility. One of the antibody-selected variants, Res 22, surprisingly also exhibited a slight difference from the original virus in the mobility of the HA. The HAs of both variants selected with HC 142 had the same mobility as the HA of the original virus. These data suggest that the actual changes in the HA molecule leading to the unusual reactivity with HC 125 and 
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* Reduction in infectivity and haemagglutination titres after contact with an excess of antibody. The initial haemagglutination titres were 1:64 or 1:128, and the initial infectivity ranged from 107.7 to 1085. t-, Reduction in titre was less than twofold in the HI test and less than tenfold in the VN test. ND, Not done. (Caton et al., 1982) ; XIIp has the same substitution and an additional one at position 89 (Thr -~ Ala). Both substitutions remove glycosylation sites, which, most likely, explains the differences in the mobility of HA (Fig. 1 b) . The results presented suggest that virus variants that were not neutralized by a monoclonal antibody retain the ability to bind the antibody in a manner adequate to ensure the inhibition of haemagglutination and the reduction of infectivity after the addition of anti-immunoglobulin serum. A rather similar situation has been described for Newcastle disease virus (Nishikawa et al., 1983 ; Russell et al., 1983) . As reported by Nishikawa et al. (1983) , one monoclonal antibody reacted with the virus in the HI test, but not in the VN test, and it overlapped partially with a group of antibodies reacting with the virus in both tests; it seems that in a similar manner the epitope of HC 125 and HC 142 monoclonal antibodies overlaps with the epitope of HC 22.
For influenza virus, the dissociation of HI and VN of the kind described in this paper has been registered only for the Fab fragment (Yoden et al., 1985) . An inverse situation, that is, an efficient neutralization of infectivity with concomitant lack of HI activity, as described by Yoden et al. (1982) and Kida et al. (1982) , seems to indicate the existence of the mechanism of infectivity neutralization differing from the block of attachment to cell receptors (Kida et al., 1983) . The data presented in this paper are perhaps best explained on the basis of assumption of a difference in the specificity and/or avidity of the receptors in red blood cells and the cells of chorioallantoic membranes. We carried out HI tests using guinea-pig and human red blood cells and the results were identical to those obtained with chicken red blood cells (Table 1) . However, the HA titres themselves differed slightly between red blood cells of different species, and the (Table 4 ). It seems possible that the mutations in the variants affect the receptor site rather than the epitope of the antibody-binding site, or the position of the antigenic site with respect to the receptor-binding region may be changed. Another interpretation is that the antigenic site must have a particular structure for neutralization to occur.
